000 | 04072cam a2200253 a 4500 | ||
---|---|---|---|
005 | 20160129124738.0 | ||
008 | 101007s2011 njua b 001 0 eng c | ||
020 | _a9781603271974 | ||
020 | _a160327197X | ||
041 | _aeng | ||
082 | 0 | 0 |
_a338.476151 _bMCN |
245 | 0 | 0 |
_aCharacterization of nanoparticles intended for drug delivery / _cedited by Scott E. McNeil. |
260 |
_aNew York : _bHumana Press _cc2011. |
||
300 |
_axii, 269 p. : _ehbk |
||
490 | 1 | _aMethods in molecular biology, | |
490 | 1 | _aSpringer protocols | |
505 | 0 | _aUnique benefits of nanotechnology to drug delivery and diagnostics / Scott E. McNeil -- Challenges for nanoparticle characterization / Scott E. McNeil -- Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review / Katherine Tyner and Nakissa Sadrieh -- Measuring the hydrodynamic size of nanoparticles in aqueous media using batch-mode dynamic light scattering / Vincent A. Hackley and Jeffrey D. Clogston -- Characterization of nanoparticles by matrix assisted laser desorption ionization time-of-flight mass spectrometry / Uma Ramalinga ... [et al.] -- Zeta potential measurement / Jeffrey D. Clogston and Anil K. Patri -- Size measurement of nanoparticles using atomic force microscopy / Jaroslaw Grobelny ... [et al.] -- Biological tissue and cell culture specimen preparation for TEM nanoparticle characterization / Kunio Nagashima ... [et al.] -- SEM x-ray microanalysis of nanoparticles present in tissue or cultured cell thin sections / Jiwen Zheng ... [et al.] -- Detecting and measuring free gadolinium in nanoparticles for MRI imaging / Jeffrey D. Clogston and Anil K. Patri -- Lipid component quantitation by thin layer chromatography / Jeffrey D. Clogston and Anil K. Patri -- Detection and quantitative evaluation of endotoxin contamination in nanoparticle formulations by LAL-based assays / Barry W. Neun and Marina A. Dobrovolskaia -- Analysis of microbial contamination in nanoparticle formulations / Timothy M. Potter and Marina A. Dobrovolskaia -- Gold nanoparticle quantitation via fluorescence in solution and cell culture / Parag Aggarwal and Marina A. Dobrovolskaia -- Quantitation of nanoparticles in serum matrix by capillary electrophoresis / King C. Chan, Timothy D. Veenstra, and Haleem J. Issaq -- Evaluation of cytotoxicity of nanoparticulate materials in porcine kidney cells and human hepatocarcinoma cells / Timothy M. Potter and Stephan T. Stern -- Monitoring nanoparticle-treated hepatocarcinoma cells for apoptosis / Timothy M. Potter and Stephan T. Stern -- Detecting reactive oxygen species in primary hepatocytes treated with nanoparticles / Banu Zolnik, Timothy M. Potter, and Stephan T. Stern -- Assay to detect lipid peroxidation upon exposure to nanoparticles / Timothy M. Potter, Barry W. Neun, and Stephan T. Stern -- Monitoring glutathione homeostasis in nanoparticle-treated hepatocytes / Timothy M. Potter, Barry W. Neun, and Stephan T. Stern -- Autophagy monitoring assay : qualitative analysis of MAP LC3-I to II conversion by immunoblot / Christopher B. McLeland, Jamie Rodriguez, and Stephan T. Stern -- Monitoring lysosomal activity in nanoparticle-treated cells / Barry W. Neun and Stephan T. Stern -- Method for analysis of nanoparticle hemolytic properties in vitro / Barry W. Neun and Marina A. Dobrovolskaia -- Method for in vitro analysis of nanoparticle thrombogenic properties / Barry W. Neun and Marina A. Dobrovolskaia -- Qualitative analysis of total complement activation by nanoparticles / Barry W. Neun and Marina A. Dobrovolskaia -- Method for analysis of nanoparticle effects on cellular chemotaxis / Sarah L. Skoczen, Timothy M. Potter, and Marina A. Dobrovolskaia -- In vitro analysis of nanoparticle uptake by macrophages using chemiluminescence / Sarah L. Skoczen, Timothy M. Potter, and Marina A. Dobrovolskaia. | |
650 | 0 |
_aNanoparticles. _96876 |
|
650 | 0 |
_aDrug delivery systems. _96879 |
|
650 | 0 |
_aPharmaceutical biotechnology. _918 |
|
650 | 0 |
_aNanomedicine. _98209 |
|
700 | 1 |
_aMcNeil, Scott E. _98210 |
|
942 | _cBK | ||
999 |
_c29618 _d29618 |